RxNorm Semantic Concepts Index - 386
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "386".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 386000 | fosfestrol Oral Tablet [Honvan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386002 | nisoldipine Extended Release Oral Tablet [Syscor MR] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386003 | clotrimazole Topical Powder [Canesten AF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386004 | diphenhydrAMINE Oral Tablet [Paxidorm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386004 | diphenhydrAMINE Oral Tablet [Paxidorm] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 386005 | moxonidine Oral Tablet [Physiotens] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386006 | benzoyl peroxide Topical Cream [PanOxyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386007 | hydrogen peroxide Topical Cream [Crystacide] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386008 | compound benzoin tincture (USP) 45 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 386009 | compound benzoin tincture (USP) Gas for Inhalation | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 386012 | amiloride / furosemide Oral Tablet [Frusemek] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386012 | amiloride / furosemide Oral Tablet [Frusemek] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 386013 | loperamide Oral Solution [Imodium] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386014 | erythromycin Oral Suspension [Erymin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386015 | tolfenamic acid Oral Capsule [Clotam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386017 | magnesium aspartate Oral Tablet [Magnesiocard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386019 | deflazacort Oral Tablet [Calcort] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386020 | proparacaine Ophthalmic Solution [Minims Proxymetacaine hydrochloride] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386021 | cetrimide / dimethicone Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 386022 | selegiline Oral Tablet [Vivapryl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386026 | selegiline Oral Tablet [Stilline] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386027 | nystatin Oral Suspension [Nystamont] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386028 | cisatracurium Injectable Solution [Nimbex Forte] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386029 | sulpiride Oral Tablet [Dogmatil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386030 | aceclofenac Oral Tablet [Preservex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386031 | levocabastine Nasal Spray [Livostin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386034 | lofepramine Oral Suspension [Lomont] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386036 | clotrimazole Topical Spray [Canesten AF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386038 | procyclidine Oral Tablet [Muscinil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386041 | cefaclor Oral Capsule [Keftid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386049 | acyclovir Topical Cream [Herpetad Cold Sore] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386050 | cefaclor Oral Suspension [Keftid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386051 | lauromacrogols 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 386054 | indomethacin Extended Release Oral Capsule [Indotard MR] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386055 | lauromacrogols | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386055 | lauromacrogols | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386055 | lauromacrogols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 386056 | reboxetine Oral Tablet [Edronax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386057 | hydrotalcite Oral Tablet [Altacite] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386058 | dipyridamole Extended Release Oral Capsule [Persantin Retard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386061 | clobazam Oral Tablet [Frisium] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386061 | clobazam Oral Tablet [Frisium] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 386062 | tolfenamic acid Oral Tablet [Clotam Rapid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386063 | acetaminophen Oral Suspension [Medinol Over Six] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386066 | piroxicam Topical Gel [Feldene P] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386068 | ampicillin Oral Capsule [Ampitrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386069 | acyclovir Topical Cream [Soothelip Cold Sore] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386070 | ampicillin Oral Suspension [Ampitrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386071 | methadone Oral Solution [Methex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386074 | floxacillin Oral Capsule [Flucloxin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386075 | floxacillin Oral Suspension [Flucloxin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386076 | HYDROmorphone Oral Capsule [Palladone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386076 | HYDROmorphone Oral Capsule [Palladone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 386077 | fluconazole Oral Capsule [Diflucan One] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386079 | penicillin V Oral Tablet [Tenkicin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386080 | tazarotene Topical Gel [Zorac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386083 | insulin, regular, beef Injectable Solution [Hypurin Bovine Neutral] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386084 | insulin isophane Injectable Suspension [Hypurin Bovine Isophane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386086 | Hypurin Porcine Neutral | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386087 | insulin, regular, pork Injectable Solution [Hypurin Porcine Neutral] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386088 | Hypurin Porcine Isophane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386089 | insulin isophane Injectable Suspension [Hypurin Porcine Isophane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 38609 | Triclocarban | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38609 | Triclocarban | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 38609 | Triclocarban | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 38609 | Triclocarban | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 38609 | Triclocarban | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38609 | Triclocarban | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38609 | Triclocarban | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38609 | Triclocarban | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 38609 | Triclocarban | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386090 | miconazole Topical Cream [Daktarin Dual Action] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386091 | lente insulin, beef Injectable Suspension [Hypurin Bovine Lente] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386092 | insulin, protamine zinc, beef Injectable Suspension [Hypurin Bovine Protamine Zinc] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386095 | loperamide Oral Capsule [Lodiar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386098 | insulin isophane / insulin, regular, pork Injectable Suspension [Hypurin Porcine Biphasic Isophane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386099 | morphine Extended Release Oral Capsule [Zomorph] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 38610 | Trichlorethyl phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38610 | Trichlorethyl phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 38610 | Trichlorethyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 38610 | Trichlorethyl phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38610 | Trichlorethyl phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38610 | Trichlorethyl phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386101 | ondansetron Rectal Suppository [Zofran] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386102 | lercanidipine Oral Tablet [Zanidip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386108 | Prepulsid Quicklet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386109 | cisapride Oral Tablet [Prepulsid Quicklet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386116 | troglitazone Oral Tablet [Romozin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386120 | amylase 600 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 386124 | indomethacin Extended Release Oral Capsule [Pardelprin MR] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386125 | amisulpride Oral Tablet [Solian] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386126 | zopiclone Oral Tablet [Zileze 7.5] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386127 | zopiclone Oral Tablet [Zileze 3.75] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386128 | flutamide Oral Tablet [Chimax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386129 | mebeverine Oral Tablet [Equilon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386130 | fusafungin 0.5 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 386131 | fusafungin Nasal Spray [Locabiotal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386132 | fusafungin Oral Spray [Locabiotal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386134 | Eumydrin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386135 | atropine Oral Solution [Eumydrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386136 | piperidolate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 386137 | Dactil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386138 | piperidolate Oral Tablet [Dactil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386139 | bismuth subgallate 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 386140 | bismuth subgallate Rectal Suppository | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 386141 | alverine Oral Capsule [Spasmonal Forte] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386142 | carbenoxolone Oral Tablet [Biogastrone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386143 | carbenoxolone Oral Tablet [Duogastrone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386144 | mizolastine Extended Release Oral Tablet [Mizollen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386145 | sennosides, USP 0.0055 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 386146 | dicobalt edetate Injectable Solution [Kelocyanor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386147 | Centyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386148 | bendroflumethiazide Oral Tablet [Centyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386149 | bendroflumethiazide Oral Tablet [Aprinox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386150 | bendroflumethiazide Oral Tablet [Berkozide] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386151 | bendroflumethiazide Oral Tablet [Neo-Bendromax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386152 | Urizid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386153 | bendroflumethiazide Oral Tablet [Urizid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386154 | bendroflumethiazide Oral Tablet [Neo-NaClex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386155 | bumetanide Oral Tablet [Burinex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386156 | Eraldin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386157 | practolol Injectable Solution [Eraldin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386158 | Slow-Pren | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386159 | oxprenolol Extended Release Oral Tablet [Slow-Pren] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386160 | oxprenolol Extended Release Oral Tablet [Slow Trasicor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386162 | oxprenolol Extended Release Oral Tablet [Trasicor Retard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386163 | pindolol Oral Tablet [Betadren] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386164 | reserpine Oral Tablet [Serpasil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386165 | Hypercal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386166 | Rauwolfia alkaloids Oral Tablet [Hypercal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386167 | Rauwiloid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386168 | Rauwolfia alkaloids Oral Tablet [Rauwiloid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 38617 | tridihexethyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 38617 | tridihexethyl | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38617 | tridihexethyl | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386170 | lidoflazine Oral Tablet [Clinium] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386171 | Cyclobral | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386172 | cyclandelate Oral Capsule [Cyclobral] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386173 | cyclandelate Oral Tablet [Cyclospasmol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386174 | cyclandelate Oral Suspension [Cyclospasmol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386176 | acenocoumarol Oral Tablet [Sinthrome] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386177 | Vasyrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386178 | dipyridamole Oral Tablet [Vasyrol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386179 | dipyridamole Oral Tablet [Cerebrovase] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386180 | dipyridamole Oral Tablet [Modaplate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386181 | ethamsylate Oral Tablet [Dicynone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386183 | Numotac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386184 | isoetharine Extended Release Oral Tablet [Numotac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386189 | Mucolex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386190 | carbocysteine Oral Tablet [Mucolex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386193 | Mucodyne Forte | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386195 | Dimyril | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386196 | isoaminile Oral Solution [Dimyril] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386197 | ciprofloxacin Oral Suspension [Ciproxin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386198 | dichloralphenazone Oral Tablet [Welldorm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386200 | Nitrados | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386201 | nitrazepam Oral Tablet [Nitrados] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386202 | Noctesed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386203 | nitrazepam Oral Tablet [Noctesed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386204 | nitrazepam Oral Tablet [Somnite] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386205 | Unisomnia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386206 | nitrazepam Oral Tablet [Unisomnia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386207 | nitrazepam Oral Tablet [Mogadon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386208 | nitrazepam Oral Tablet [Remnos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386209 | Surem | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386210 | nitrazepam Oral Capsule [Surem] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386211 | nitrazepam Oral Capsule [Mogadon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386212 | Anxon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386213 | ketazolam Oral Capsule [Anxon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386214 | medazepam Oral Capsule [Nobrium] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386215 | Oxanid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386216 | oxazepam Oral Tablet [Oxanid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386217 | prazepam Oral Tablet [Centrax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386218 | amobarbital Oral Tablet [Amytal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386219 | Phanodorm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386220 | cyclobarbital Oral Tablet [Phanodorm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386221 | methyprylon Oral Tablet [Noludar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386222 | chlorproMAZINE Rectal Suppository [Largactil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386222 | chlorproMAZINE Rectal Suppository [Largactil] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 386223 | chlorprothixene Oral Tablet [Taractan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386224 | haloperidol Oral Tablet [Serenace] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386225 | Integrin brand of oxypertine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386226 | oxypertine Oral Capsule [Integrin brand of oxypertine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386227 | oxypertine Oral Tablet [Integrin brand of oxypertine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386228 | perphenazine Oral Tablet [Fentazin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386229 | perphenazine Injectable Solution [Fentazin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 38623 | trolamine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 38623 | trolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 38623 | trolamine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 38623 | trolamine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 38623 | trolamine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 38623 | trolamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 38623 | trolamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 386230 | Optimax WV | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386231 | tryptophan Oral Tablet [Optimax WV] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386232 | Pacitron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386233 | tryptophan Oral Tablet [Pacitron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386234 | tryptophan Oral Tablet [Optimax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386235 | Claradin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386236 | aspirin Oral Tablet [Claradin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386237 | aspirin Oral Solution [Solprin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386238 | acetaminophen Oral Capsule [Panadol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386239 | acetaminophen Oral Capsule [Paracets] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 38624 | triethanolamine polypeptide oleate condensate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 386240 | Panasorb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 386241 | acetaminophen Oral Tablet [Panasorb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386242 | acetaminophen Oral Tablet [Fanalgic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386243 | acetaminophen Oral Solution [Panadol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386246 | dextromoramide Injectable Solution [Palfium] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 38625 | triethanolamine stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 386250 | beclamide Oral Tablet [nydrane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 386252 | trihexyphenidyl Extended Release Oral Capsule [Artane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 38655 | triflusal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 38655 | triflusal | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38655 | triflusal | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38668 | trilostane | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 38668 | trilostane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 38668 | trilostane | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 38668 | trilostane | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 38668 | trilostane | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 38678 | Trimetaphosphatase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38678 | Trimetaphosphatase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38680 | Trimetaphan camsilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 38680 | Trimetaphan camsilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38680 | Trimetaphan camsilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 38680 | Trimetaphan camsilate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 38680 | Trimetaphan camsilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 38680 | Trimetaphan camsilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38681 | Trimethidinium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38681 | Trimethidinium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386841 | Echinocandin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386841 | Echinocandin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386841 | Echinocandin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386841 | Echinocandin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38685 | trimethobenzamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 38685 | trimethobenzamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 38685 | trimethobenzamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 38685 | trimethobenzamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 38685 | trimethobenzamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 386857 | Substance with protein-tyrosine kinase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386857 | Substance with protein-tyrosine kinase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386857 | Substance with protein-tyrosine kinase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386857 | Substance with protein-tyrosine kinase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386857 | Substance with protein-tyrosine kinase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386862 | 3(or 17)-alpha-hydroxysteroid dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386862 | 3(or 17)-alpha-hydroxysteroid dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386863 | Progesterone reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386863 | Progesterone reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386863 | Progesterone reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386863 | Progesterone reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386864 | 3-oxoacyl-[acyl-carrier protein] reductase (reduced nicotinamide adenine dinucleotide) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386864 | 3-oxoacyl-[acyl-carrier protein] reductase (reduced nicotinamide adenine dinucleotide) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386864 | 3-oxoacyl-[acyl-carrier protein] reductase (reduced nicotinamide adenine dinucleotide) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386865 | 3-alpha-hydroxysteroid dehydrogenase (A-specific) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386865 | 3-alpha-hydroxysteroid dehydrogenase (A-specific) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386866 | Benzyl 2-methyl-3-hydroxybutyrate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386866 | Benzyl 2-methyl-3-hydroxybutyrate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386866 | Benzyl 2-methyl-3-hydroxybutyrate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386867 | Vomifoliol 4'-dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386867 | Vomifoliol 4'-dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386868 | (R)-aromatic lactate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386868 | (R)-aromatic lactate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386868 | (R)-aromatic lactate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386869 | NADPH-mannose-6-P reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386869 | NADPH-mannose-6-P reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386869 | NADPH-mannose-6-P reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386869 | NADPH-mannose-6-P reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386870 | 4-hydroxycyclohexanecarboxylate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386870 | 4-hydroxycyclohexanecarboxylate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386871 | (-)-borneol dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386871 | (-)-borneol dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386872 | Diethyl 2-methyl-3-oxosuccinate reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386872 | Diethyl 2-methyl-3-oxosuccinate reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386873 | 15-hydroxyicosatetraenoate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386873 | 15-hydroxyicosatetraenoate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386874 | Flavonone 4-reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386874 | Flavonone 4-reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386875 | 8-oxocoformycin reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386875 | 8-oxocoformycin reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386876 | Hydroxyphenylpyruvate reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386876 | Hydroxyphenylpyruvate reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386877 | N-acetylhexosamine 1-dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386877 | N-acetylhexosamine 1-dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386878 | 6-endo-hydroxycineole dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386878 | 6-endo-hydroxycineole dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386879 | Zeatin reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386879 | Zeatin reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386880 | Cyclohexanol dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386880 | Cyclohexanol dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386881 | Pterocarpin synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386881 | Pterocarpin synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386882 | Salutaridine reductase (reduced nicotinamide adenine dinucleotide phosphate) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386882 | Salutaridine reductase (reduced nicotinamide adenine dinucleotide phosphate) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386882 | Salutaridine reductase (reduced nicotinamide adenine dinucleotide phosphate) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386883 | D-arabinitol 2-dehydrogenase (ribulose-forming) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386883 | D-arabinitol 2-dehydrogenase (ribulose-forming) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386883 | D-arabinitol 2-dehydrogenase (ribulose-forming) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386884 | Galactitol-1-phosphate 5-dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386884 | Galactitol-1-phosphate 5-dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386885 | D-carnitine dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386885 | D-carnitine dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386885 | D-carnitine dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386886 | Berberine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386886 | Berberine synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386886 | Berberine synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386887 | Hydroxyphytanate oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386887 | Hydroxyphytanate oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386888 | Nucleoside oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386888 | Nucleoside oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386889 | N-acylhexosamine oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386889 | N-acylhexosamine oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386890 | (S)-cheilanthifoline oxidase (methylenedioxy-bridge-forming) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386890 | (S)-cheilanthifoline oxidase (methylenedioxy-bridge-forming) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386890 | (S)-cheilanthifoline oxidase (methylenedioxy-bridge-forming) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386891 | (S)-scoulerine oxidase (methylenedioxy-bridge-forming) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386891 | (S)-scoulerine oxidase (methylenedioxy-bridge-forming) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386891 | (S)-scoulerine oxidase (methylenedioxy-bridge-forming) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386892 | (R)-reticuline oxidase (C-C phenol-coupling) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386892 | (R)-reticuline oxidase (C-C phenol-coupling) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386892 | (R)-reticuline oxidase (C-C phenol-coupling) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386893 | (S)-tetrahydrocolumbamine oxidase (methylenedioxy-bridge-forming) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386893 | (S)-tetrahydrocolumbamine oxidase (methylenedioxy-bridge-forming) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386893 | (S)-tetrahydrocolumbamine oxidase (methylenedioxy-bridge-forming) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386893 | (S)-tetrahydrocolumbamine oxidase (methylenedioxy-bridge-forming) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386894 | D-sorbitol dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386894 | D-sorbitol dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386894 | D-sorbitol dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386895 | Glycerol dehydrogenase (acceptor) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386895 | Glycerol dehydrogenase (acceptor) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386896 | Autologous packed red cells preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386896 | Autologous packed red cells preparation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386896 | Autologous packed red cells preparation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386897 | Autologous whole blood preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386897 | Autologous whole blood preparation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386897 | Autologous whole blood preparation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386921 | D-methamphetamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386921 | D-methamphetamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386921 | D-methamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386925 | Plasma expander | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386925 | Plasma expander | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386925 | Plasma expander | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386927 | Substance with lipase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386927 | Substance with lipase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386927 | Substance with lipase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386927 | Substance with lipase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386927 | Substance with lipase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386928 | Substance with gonadotropin releasing hormone receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386928 | Substance with gonadotropin releasing hormone receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386928 | Substance with gonadotropin releasing hormone receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386928 | Substance with gonadotropin releasing hormone receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386928 | Substance with gonadotropin releasing hormone receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386930 | Magnesium supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386930 | Magnesium supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386932 | Antineoplastic anthraquinone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386932 | Antineoplastic anthraquinone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386937 | Amino acid derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386937 | Amino acid derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386937 | Amino acid derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386937 | Amino acid derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386938 | Follitropin alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 386938 | Follitropin alfa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 386938 | Follitropin alfa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 386938 | Follitropin alfa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 386938 | Follitropin alfa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 386939 | Substance with alcohol dehydrogenase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386939 | Substance with alcohol dehydrogenase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386939 | Substance with alcohol dehydrogenase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386939 | Substance with alcohol dehydrogenase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386939 | Substance with alcohol dehydrogenase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386943 | Substance with protease inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386943 | Substance with protease inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386943 | Substance with protease inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386943 | Substance with protease inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386943 | Substance with protease inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386947 | Purine analog | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386947 | Purine analog | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386947 | Purine analog | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386947 | Purine analog | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386947 | Purine analog | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 386947 | Purine analog | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 38695 | Trimethylamine dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38695 | Trimethylamine dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386950 | Mast cell stabiliser-containing product | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 386950 | Mast cell stabiliser-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386950 | Mast cell stabiliser-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386950 | Mast cell stabiliser-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386950 | Mast cell stabiliser-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386950 | Mast cell stabiliser-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386956 | Alpha/beta-adrenergic blocking agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386956 | Alpha/beta-adrenergic blocking agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386957 | Product containing phthalazinone derivative (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386957 | Product containing phthalazinone derivative (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386957 | Product containing phthalazinone derivative (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386957 | Product containing phthalazinone derivative (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386958 | Piperidine derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386958 | Piperidine derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386958 | Piperidine derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386958 | Piperidine derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386959 | Histaminase agent (substance) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386959 | Histaminase agent (substance) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38696 | Trimethylamine-N-oxide reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38696 | Trimethylamine-N-oxide reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386962 | Fungal agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386962 | Fungal agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386962 | Fungal agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386963 | Anxiolytic, sedative AND/OR hypnotic | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386963 | Anxiolytic, sedative AND/OR hypnotic | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 38697 | Trimethylamine-oxide aldolase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 38697 | Trimethylamine-oxide aldolase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386974 | UEA-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386974 | UEA-1 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386974 | UEA-1 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386976 | MGAT | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386976 | MGAT | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386976 | MGAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386977 | Variant-surface-glycoprotein phospholipase C | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386977 | Variant-surface-glycoprotein phospholipase C | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386978 | Limulus clotting enzyme | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386978 | Limulus clotting enzyme | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386989 | calcium 500 MG / vitamin D3 10 MCG (400 UNT) Chewable Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 386989 | calcium 500 MG / vitamin D3 10 MCG (400 UNT) Chewable Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 386989 | calcium 500 MG / vitamin D3 10 MCG (400 UNT) Chewable Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 386989 | calcium 500 MG / vitamin D3 10 MCG (400 UNT) Chewable Tablet, as calcium carbonate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 386989 | calcium 500 MG / vitamin D3 10 MCG (400 UNT) Chewable Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 386989 | calcium 500 MG / vitamin D3 10 MCG (400 UNT) Chewable Tablet, as calcium carbonate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 386992 | Escherichia coli asparaginase II | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386992 | Escherichia coli asparaginase II | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386992 | Escherichia coli asparaginase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386998 | Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386999 | cysteamine 0.1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 386999 | cysteamine 0.1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386999 | cysteamine 0.1 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 386999 | cysteamine 0.1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 386999 | cysteamine 0.1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 386999 | cysteamine 0.1 % Ophthalmic Solution | Full form of descriptor (FN) | NO |